Profiling the mRNA and miRNA in Peripheral Blood Mononuclear Cells in Subjects with Active Tuberculosis

References

• Bao H, Liu K, Wu Z, et al. Tuberculosis among full-time teachers in Southeast China, 2005–2016. Int J Environ Res Public Health. 2018;15(9).
   Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report; 2019 Available from: https://www.who.int/tb/publications/global_report/en/. Accessed 1109, 2020.
   Google Scholar
• Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642–1656. doi:10.1016/S0140-6736(19)30308-330904262
   PubMed Web of Science ®Google Scholar
• Tiberi S, Du Plessis N, Walzl G, et al. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018;18(7):e183–e198. doi:10.1016/S1473-3099(18)30110-5
   PubMed Web of Science ®Google Scholar
• Wen A, Qu XH, Zhang KN, Leng EL, Ren Y, Wu XM. Evaluation of interferon-gamma release assays in extrasanguinous body fluids for diagnosing tuberculosis: a systematic review and meta-analysis. Life Sci. 2018;197:140–146. doi:10.1016/j.lfs.2018.02.00429421440
   PubMed Web of Science ®Google Scholar
• Yang J, He J, Huang H, et al. Molecular characterization of T cell receptor beta variable in the peripheral blood T cell repertoire in subjects with active tuberculosis or latent tuberculosis infection. BMC Infect Dis. 2013;13:423. doi:10.1186/1471-2334-13-42324010943
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–858. doi:10.1126/science.106492111679670
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–355. doi:10.1038/nature0287115372042
   PubMed Web of Science ®Google Scholar
• KK GA F, Jan C, Lewis BP, et al. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science. 2005;310:1817–1821. doi:10.1126/science.112115816308420
   PubMed Web of Science ®Google Scholar
• Kumar M, Sahu SK, Kumar R, et al. MicroRNA let-7 modulates the immune response to Mycobacterium tuberculosis infection via control of A20, an inhibitor of the NF-kappaB pathway. Cell Host Microbe. 2015;17(3):345–356. doi:10.1016/j.chom.2015.01.00725683052
   PubMed Web of Science ®Google Scholar
• Qi Y, Cui L, Ge Y, et al. Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection. BMC Infect Dis. 2012;12:384. doi:10.1186/1471-2334-12-38423272999
   PubMed Web of Science ®Google Scholar
• Kathirvel M, Saranya S, Mahadevan S. Expression levels of candidate circulating microRNAs in pediatric tuberculosis. Pathog Glob Health. 2020;114(5):262–270. doi:10.1080/20477724.2020.176114032401176
   PubMed Web of Science ®Google Scholar
• Migliori GB, Sotgiu G, Rosales-Klintz S, et al. ERS/ECDC statement: European Union standards for tuberculosis care, 2017 update. Eur Respir J. 2018;51(5).
   Web of Science ®Google Scholar
• Liao R, Lv Y, Zhu L, Lin Y. Altered expression of miRNAs and mRNAs reveals the potential regulatory role of miRNAs in the developmental process of early weaned goats. PLoS One. 2019;14(8):e0220907.31393969
   PubMed Web of Science ®Google Scholar
• Houben RM, Glynn JR, Mallard K, et al. Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection. Int J Tuberc Lung Dis. 2010;14:909–915.20550777
   PubMed Web of Science ®Google Scholar
• Wang C, Yang S, Sun G, et al. Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PLoS One. 2011;6(10):e25832. doi:10.1371/journal.pone.002583222003408
   PubMed Web of Science ®Google Scholar
• Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 2009;27:393–422. doi:10.1146/annurev.immunol.021908.13270319302046
   PubMed Web of Science ®Google Scholar
• Natarajan K, Kundu M, Sharma P, Basu J. Innate immune responses to M. tuberculosis infection. Tuberculosis (Edinb). 2011;91(5):427–431. doi:10.1016/j.tube.2011.04.00321550855
   PubMed Web of Science ®Google Scholar
• Domingo-Gonzalez R, Prince O, Cooper A, Khader SA. Cytokines and chemokines in Mycobacterium tuberculosis infection. Microbiol Spectr. 2016;4(5). doi:10.1128/microbiolspec.TBTB2-0018-2016
   PubMed Web of Science ®Google Scholar
• Amaral EP, Lasunskaia EB, D’Imperio-Lima MR. Innate immunity in tuberculosis: how the sensing of mycobacteria and tissue damage modulates macrophage death. Microbes Infect. 2016;18(1):11–20. doi:10.1016/j.micinf.2015.09.00526369715
   PubMed Web of Science ®Google Scholar
• Shen HB, Chen ZW. The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection. Cell Mol Immunol. 2018;15(3):216–225. doi:10.1038/cmi.2017.12829176747
   PubMed Web of Science ®Google Scholar
• Choi HG, Kwon KW, Choi S, et al. Antigen-specific IFN-gamma/IL-17-co-producing CD4(+) T-cells are the determinants for protective efficacy of tuberculosis subunit vaccine. Vaccines (Basel). 2020;8(2).
   Web of Science ®Google Scholar
• Sabir N, Hussain T, Mangi MH, Zhao D, Zhou X. Matrix metalloproteinases: expression, regulation and role in the immunopathology of tuberculosis. Cell Prolif. 2019;52(4):e12649. doi:10.1111/cpr.1264931199047
   PubMed Web of Science ®Google Scholar
• Parasa VR, Muvva JR, Rose JF, Braian C, Brighenti S, Lerm M. Inhibition of tissue matrix metalloproteinases interferes with Mycobacterium tuberculosis-induced granuloma formation and reduces bacterial load in a human lung tissue model. Front Microbiol. 2017;8:2370. doi:10.3389/fmicb.2017.0237029259583
   PubMed Web of Science ®Google Scholar
• Walker NF, Clark SO, Oni T, et al. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. Am J Respir Crit Care Med. 2012;185(9):989–997. doi:10.1164/rccm.201110-1769OC22345579
   PubMed Web of Science ®Google Scholar
• Ordonez AA, Pokkali S, Kim S, et al. Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas. PLoS One. 2018;13(5):e0197474. doi:10.1371/journal.pone.019747429758082
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, Zimmerman MD, et al. Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. PLoS Pathog. 2018;14(4):e1006974. doi:10.1371/journal.ppat.100697429698476
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Schwartz AL. The ubiquitin system: pathogenesis of human diseases and drug targeting. Biochim Biophys Acta. 2004;1695(1–3):3–17. doi:10.1016/j.bbamcr.2004.09.01815571805
   PubMed Web of Science ®Google Scholar
• Liu X, Wang Q, Chen W, Wang C. Dynamic regulation of innate immunity by ubiquitin and ubiquitin-like proteins. Cytokine Growth Factor Rev. 2013;24(6):559–570. doi:10.1016/j.cytogfr.2013.07.00223953672
   PubMed Web of Science ®Google Scholar
• Cheng Y, Kiene NJ, Tatarian A, Eix EF, Schorey JS, Hawn TR. Host cytosolic RNA sensing pathway promotes T Lymphocyte-mediated mycobacterial killing in macrophages. PLoS Pathog. 2020;16(5):e1008569. doi:10.1371/journal.ppat.100856932463840
   PubMed Web of Science ®Google Scholar
• Jia J, Bissa B, Brecht L, et al. AMPK, a regulator of metabolism and autophagy, is activated by lysosomal damage via a novel galectin-directed ubiquitin signal transduction system. Mol Cell. 2020;77(5):951–969 e959. doi:10.1016/j.molcel.2019.12.02831995728
   PubMed Web of Science ®Google Scholar
• Chai Q, Wang X, Qiang L, et al. A Mycobacterium tuberculosis surface protein recruits ubiquitin to trigger host xenophagy. Nat Commun. 2019;10(1):1973. doi:10.1038/s41467-019-09955-831036822
   PubMed Web of Science ®Google Scholar
• Fu B, Xue W, Zhang H, et al. MicroRNA-325-3p facilitates immune escape of Mycobacterium tuberculosis through targeting LNX1 via NEK6 accumulation to promote anti-apoptotic STAT3 signaling. mBio. 2020;11(3). doi:10.1128/mBio.00557-20.
   Web of Science ®Google Scholar
• Monin L, Khader SA. Chemokines in tuberculosis: the good, the bad and the ugly. Semin Immunol. 2014;26(6):552–558. doi:10.1016/j.smim.2014.09.00425444549
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li S, Liu Q, et al. Mycobacterium tuberculosis heat-shock protein 16.3 induces macrophage M2 polarization through CCRL2/CX3CR1. Inflammation. 2020;43(2):487–506. doi:10.1007/s10753-019-01132-931748849
   PubMed Web of Science ®Google Scholar
• Brilha S, Ong CWM, Weksler B, Romero N, Couraud PO, Friedland JS. Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis. Sci Rep. 2017;7(1):16031. doi:10.1038/s41598-017-16250-329167512
   PubMed Web of Science ®Google Scholar
• Shi K, Li N, Yang M, Li W. Identification of key genes and pathways in female lung cancer patients who never smoked by a bioinformatics analysis. J Cancer. 2019;10(1):51–60. doi:10.7150/jca.2690830662525
   PubMed Web of Science ®Google Scholar
• Guo L, Zhao J, Qu Y, et al. microRNA-20a inhibits autophagic process by targeting ATG7 and ATG16L1 and favors mycobacterial survival in macrophage cells. Front Cell Infect Microbiol. 2016;6:134. doi:10.3389/fcimb.2016.0013427803889
   PubMed Web of Science ®Google Scholar
• Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell. 2008;132(1):9–14. doi:10.1016/j.cell.2007.12.02418191211
   PubMed Web of Science ®Google Scholar
• Rebane A, Akdis CA. MicroRNAs: essential players in the regulation of inflammation. J Allergy Clin Immunol. 2013;132(1):15–26. doi:10.1016/j.jaci.2013.04.01123726263
   PubMed Web of Science ®Google Scholar
• Zhang YB, Zhang XL, Zhao ZY, Zheng YL, Xiao Z, Li F. Integrated bioinformatics analysis and validation revealed potential immune-regulatory miR-892b, miR-199b-5p and miR-582-5p as diagnostic biomarkers in active tuberculosis. Microb Pathogen. 2019;134:103563. doi:10.1016/j.micpath.2019.10356331175974
   PubMed Web of Science ®Google Scholar
• Gu X, Gao Y, Mu DG, Fu EQ. MiR-23a-5p modulates mycobacterial survival and autophagy during mycobacterium tuberculosis infection through TLR2/MyD88/NF-kappaB pathway by targeting TLR2. Exp Cell Res. 2017;354(2):71–77. doi:10.1016/j.yexcr.2017.03.03928327409
   PubMed Web of Science ®Google Scholar
• Zhang X, Guo J, Fan S, et al. Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis. PLoS One. 2013;8(12):e81076. doi:10.1371/journal.pone.008107624349033
   PubMed Web of Science ®Google Scholar
• Zhang XGJ, Fan S, Li Y, et al. High serum miR-183 level is associated with the bioactivity of macrophage derived from tuberculosis patients. Int J Clin Exp Pathol. 2015;8(1):655–659.25755759
   PubMed Web of Science ®Google Scholar
• Yi Z, Fu Y, Ji R, Li R, Guan Z, Goletti D. Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One. 2012;7(8):e43184. doi:10.1371/journal.pone.004318422900099
   PubMed Web of Science ®Google Scholar
• Zhang H, Sun Z, Wei W, et al. Identification of serum microRNA biomarkers for tuberculosis using RNA-seq. PLoS One. 2014;9(2):e88909. doi:10.1371/journal.pone.008890924586438
   PubMed Web of Science ®Google Scholar